What is Cerezyme’s structure?
Cerezyme (imiglucerase) is a recombinant form of the human enzyme glucocerebrosidase. It is produced as a glycoprotein and contains carbohydrate (glycan) chains that help the molecule be recognized and taken up by cells. [1]
What kinds of building blocks does Cerezyme have?
Like other engineered enzyme therapies, Cerezyme’s structure is built from an amino-acid protein backbone (the enzyme portion) plus attached carbohydrate side chains (glycosylation). The glycosylation pattern is part of how the drug is targeted to the relevant cells. [1]
How is Cerezyme’s structure related to its “enzyme” function?
Because Cerezyme is glucocerebrosidase, its protein structure determines how it folds and where the active-site chemistry works. The glycan portion supports delivery/uptake, while the folded protein provides catalytic function. [1]
Does Cerezyme’s structure include any “pegylation” or other modifications?
Cerezyme is a recombinant glycoprotein enzyme therapy; it is not described as a PEGylated small molecule. The key structural components discussed for Cerezyme are the protein and its glycan chains. [1]
Where can I find the most precise structural details?
Precise structural details (for example, exact sequence, glycosylation sites, or higher-resolution structure data) are typically reported in the product’s regulatory documentation and scientific literature for imiglucerase. The sources provided here only support the general description that Cerezyme is a recombinant human glucocerebrosidase glycoprotein. [1]
Sources
- https://www.drugs.com/pro/cerezyme.html